Payer Almanac
About the data Sign in
Plan reportsServicesDrugsAppeals

Drugs that need prior authorization

Every Part D plan publishes a formulary, the list of drugs it covers, and marks the ones that need its approval first (prior authorization), that must follow a cheaper drug first (step therapy), or that it covers only up to a quantity. CMS collects every formulary each month. This is the drug side of prior authorization; the plans' reports and services cover medical care. October 2026, 2027 plans.
i
Where this comes from

CMS's monthly Part D formulary files: for each plan, its formulary, and for each drug on the formulary, whether it needs prior authorization, step therapy or a quantity limit. A drug here is one RxNorm drug concept (an ingredient, strength and form); shares are of the drugs on the plan's formulary.

From October each year the files describe the next year's plans, which go on sale then, so a month-to-month change is shown only between months of the same plan year. Members: each plan's enrollment that month, or the latest month we have; for next year's plans, today's enrollment of the same contract and plan number, so new plans count zero until they have members. Contract and parent figures are member-weighted across their plans.

The share of drugs needing approval says how much of the list carries a restriction, not how often members meet one: a plan can restrict many rarely used drugs, or a few common ones.

27.4%
of covered drugs need prior authorization
Medicare Advantage drug plans (MA-PD), member-weighted
26.9%
Stand-alone drug plans (PDP)
323 plans
41%
Quantity limits, MA-PD
step therapy 0.8%
3,468
Drugs on a typical MA-PD formulary
259 formularies across 4,711 plans

Share of covered drugs needing prior authorization, by month

Member-weighted across plans. Each line is one plan year; next year's plans appear from October.

By plan: H3447, October 2026

Plan Members Drugs on formulary Prior authorizationshare of drugs Change
i
Change

Change in the share of drugs needing prior authorization since the month before (Sep), in percentage points. Only months of the same plan year are compared: October 2026 is the first month of the 2027 plan year, so there's nothing to compare yet.

vs Sep
Step therapyQuantity limit Formulary
H3447-042 Anthem Medicare Advantage (HMO-POS)Elevance Health, Inc. 45,468 3,538 29.2% — 0.2% 45% 00027020
H3447-050 Anthem Medicare Advantage 3 (HMO-POS)Elevance Health, Inc. 22,246 3,426 28.5% — 0.1% 44% 00027021
H3447-049 Anthem Medicare Advantage 3 (HMO-POS)Elevance Health, Inc. 19,244 3,426 28.5% — 0.1% 44% 00027021
H3447-038 Anthem Medicare Advantage (HMO-POS)Elevance Health, Inc. 15,601 3,538 29.2% — 0.2% 45% 00027020
H3447-039 Anthem Medicare Advantage 4 (HMO-POS)Elevance Health, Inc. 13,690 3,538 29.2% — 0.2% 45% 00027020
H3447-037 Anthem Chronic Care (HMO-POS C-SNP)Elevance Health, Inc. 6,681 3,335 29.6% — 0.1% 46% 00027022
H3447-051 Anthem Medicare Advantage 3 (HMO-POS)Elevance Health, Inc. 5,709 3,426 28.5% — 0.1% 44% 00027021
H3447-013 Anthem Medicare Advantage (HMO-POS)Elevance Health, Inc. 5,691 3,538 29.2% — 0.2% 45% 00027020
H3447-025 Anthem Medicare Advantage 2 (HMO-POS)Elevance Health, Inc. 5,189 3,538 29.2% — 0.2% 45% 00027020
H3447-018 Anthem Full Dual Advantage (HMO D-SNP)Elevance Health, Inc. 4,114 3,538 29.2% — 0.2% 45% 00027020
H3447-024 Anthem Extra Help (HMO-POS)Elevance Health, Inc. 4,107 3,538 29.2% — 0.2% 45% 00027020
H3447-053 Anthem Full Dual Advantage 2 (HMO D-SNP)Elevance Health, Inc. 3,222 3,538 29.2% — 0.2% 45% 00027020
H3447-052 Anthem Medicare Advantage 3 (HMO-POS)Elevance Health, Inc. 2,271 3,426 28.5% — 0.1% 44% 00027021
H3447-033 Anthem Kidney Care (HMO-POS C-SNP)Elevance Health, Inc. 1,606 3,538 29.2% — 0.2% 45% 00027020
H3447-056 Anthem Chronic Care (HMO-POS C-SNP)Elevance Health, Inc. 719 3,538 29.2% — 0.2% 45% 00027020

Members are projected from todays enrollment.